As of Jul 22
| -0.14 / -0.97%|
The 3 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 18.00, with a high estimate of 21.00 and a low estimate of 17.00. The median estimate represents a +25.61% increase from the last price of 14.33.
The current consensus among 3 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.